In the present scenario, cancerous tumours are common in humans due to major changes in nearby environments. Skin cancer is a considerable disease detected among people. This cancer is the uncontrolled evolution of atypical skin cells. It occurs when DNA injury to skin cells, or a genetic defect, leads to an increase quickly and establishes malignant tumors. However, in rare instances, many types of skin cancer occur from DNA changes tempted by infrared light affecting skin cells. This disease is a worldwide health problem, so an accurate and appropriate diagnosis is needed for efficient treatment. Current developments in medical technology, like smart recognition and analysis utilizing machine learning (ML) and deep learning (DL) techniques, have transformed the analysis and treatment of these conditions. These approaches will be highly effective for the recognition of skin cancer utilizing biomedical imaging. This study develops a Multi-scale Feature Fusion of Deep Convolutional Neural Networks on Cancerous Tumor Detection and Classification (MFFDCNN-CTDC) model. The main aim of the MFFDCNN-CTDC model is to detect and classify cancerous tumours using biomedical imaging. To eliminate unwanted noise, the MFFDCNN-CTDC method initially utilizes a sobel filter (SF) for the image preprocessing stage. For the segmentation process, Unet3+ is employed, providing precise localization of tumour regions. Next, the MFFDCNN-CTDC model incorporates multi-scale feature fusion by combining ResNet50 and EfficientNet architectures, capitalizing on their complementary strengths in feature extraction from varying depths and scales of the input images. The convolutional autoencoder (CAE) model is utilized for the classification method. Finally, the parameter tuning process is performed through a hybrid fireworks whale optimization algorithm (FWWOA) to enhance the classification performance of the CAE model. A wide range of experiments is performed to authorize the performance of the MFFDCNN-CTDC approach. The experimental validation of the MFFDCNN-CTDC approach exhibited a superior accuracy value of 98.78% and 99.02% over existing techniques under ISIC 2017 and HAM10000 datasets.
skin cancer detectionskin lesion classificationmulti-scale feature fusionconvolutional neural networks
Frontiers in Computational Neuroscience · مجلد 18 · 1485121-1485121
Facial emotion recognition (FER) can serve as a valuable tool for assessing emotional states, which are often linked to mental health. However, mental health encompasses a broad range of factors that go beyond facial expressions. While FER provides insights into certain aspects of emotional well-being, it can be used in conjunction with other assessments to form a more comprehensive understanding of an individual's mental health. This research work proposes a framework for human FER using UNet image segmentation and transfer learning with the EfficientNetB4 model (called FacialNet). The proposed model demonstrates promising results, achieving an accuracy of 90% for six emotion classes (happy, sad, fear, pain, anger, and disgust) and 96.39% for binary classification (happy and sad). The significance of FacialNet is judged by extensive experiments conducted against various machine learning and deep learning models, as well as state-of-the-art previous research works in FER. The significance of FacialNet is further validated using a cross-validation technique, ensuring reliable performance across different data splits. The findings highlight the effectiveness of leveraging UNet image segmentation and EfficientNetB4 transfer learning for accurate and efficient human facial emotion recognition, offering promising avenues for real-world applications in emotion-aware systems and effective computing platforms. Experimental findings reveal that the proposed approach performs substantially better than existing works with an improved accuracy of 96.39% compared to existing 94.26%.
facial emotion recognitionmental health assessmentEfficientNet-B4transfer learning
The classification of speech disorders (SDs) is crucial for treating children with speech impairment (SI). An automated SD classification can assist speech therapists in rendering services to children with SI in rural areas. Automated techniques for detecting SDs provide objective assessments of speech attributes, including articulation, fluency, and prosody. Clinical examinations and quantitative assessments provide an in-depth understanding of the patient’s speaking abilities and limitations. Existing deep learning (DL) models for SD detection often lack generalization across diverse populations and speech variations, leading to suboptimal performance when applied to individuals with different linguistic backgrounds or dialects. This study introduces a DL-based model for classifying normal and abnormal speeches using voice samples. To overcome the overfitting and bias, the authors construct convolutional neural network models with the weights of MobileNet V3 and EfficientNet B7 models for feature extraction (FE). To improve performance, they integrate the squeeze and excitation block with the MobileNet V3-based FE model. Similarly, the EfficientNet B7-model-based FE is improved using the structure pruning technique. The enhanced CatBoost model differentiates the normal and abnormal speeches using the extracted features. The experimental analysis is performed using the public dataset that contains 4620 utterances of healthy children and 2178 utterances of children with SI. The comparative study reveals the exceptional performance of the proposed SD classification model. The model outperforms the current SD classification models. It can be employed in clinical settings to support speech therapists. Substantial training with diverse voice samples can improve the generalizability of the proposed model.
The progressive nature and early identification requirements of Alzheimer’s disease (AD) provide an immense challenge in healthcare. The present study introduces a novel ensemble learning technique for detecting AD, using cutting-edge deep learning (DL) and classic machine learning (ML) techniques. The feature extraction process is carried out with YOLOv7 and EfficientNet B3 models, which effectively capture spatial and semantic information from brain imaging data. CatBoost and XGBoost are used as base learners, using gradient-boosting capabilities for classification. In order to improve the accuracy of predictions, support vector machines are used as meta-learners to effectively merge the results of the base models. We performed trials on a dataset from the Kaggle repository and achieved a remarkable average accuracy of 99.8%. Our methodology shows the effectiveness of integrating DL and classic ML methods in detecting AD. The ensemble architecture not only boosts the accuracy of classification but also improves the resilience and generalizability of the model. The study’s results indicate promising directions for advancing the development of precise and dependable diagnostic instruments for AD. The proposed research has the potential to assist medical professionals in identifying the condition at an early stage and planning appropriate interventions and treatments.
Detecting Alzheimer’s disease (AD) using magnetic resonance imaging (MRI) is essential for early diagnosis and management. This study introduces a new method for detecting AD by combining three robust models: DenseNet201, EfficientNet B7, and extremely randomized trees (ERT). We improve the ability to extract features in DenseNet201 by including a self-attention mechanism. Additionally, we use early stopping techniques on EfficientNet B7 to address the issue of overfitting. In addition, Bayesian Optimization and Hyperband optimization techniques are used to adjust the hyperparameters of extra-trees to differentiate normal and abnormal MRI images. In addition, the authors used SHapley Additive exPlanations to understand the model’s decision. With minimal computer resources, the proposed model achieved a remarkable accuracy of 98.9% in detecting AD. The findings highlight the effectiveness of recommended feature extraction and ERT models and optimization methods to accurately identify AD using MRI images.